INFINITY PHARMACEUTICALS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.96% |
| Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
| Mar. 25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
Chart calendar Infinity Pharmaceuticals, Inc.
54641935fcda8651d.MMpHGDZ4nja8fvm9ZqJab3_hNFseRe5g4Aq6hjbL7VI.W5lwbVEcqW6FCpLQNPUsBQyZZiJaP5gIoW_szHGhhGVD-R8sWQnMZfgyoA~ebb7ab94d1a708fdbf171cdc380af905
Upcoming events on Infinity Pharmaceuticals, Inc.
No events available
Past events on Infinity Pharmaceuticals, Inc.
| 2023-07-14 10:00 am | Extraordinary Shareholders Meeting - M&A Vote |
| 2023-06-19 08:00 am | Business Update Call |
| 2023-04-18 10:20 am | American Association for Cancer Research Meeting |
| 2023-04-15 08:30 am | American Association for Cancer Research Meeting |
| 2023-03-28 04:05 pm | Q4 2022 Earnings Release |
| 2022-11-29 04:00 pm | Piper Sandler Healthcare Conference |
| 2022-11-14 08:30 am | Q3 2022 Earnings Call |
| 2022-11-14 07:05 am | Q3 2022 Earnings Release |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
| 2022-09-09 08:00 am | Wells Fargo Healthcare Conference |
| 2022-08-09 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-09 04:05 pm | Interim 2022 Earnings Release |
| 2022-06-16 08:30 am | Annual General Meeting |
| 2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-03 04:30 pm | Q1 2022 Earnings Call |
| 2022-05-03 04:05 pm | Q1 2022 Earnings Release |
| 2022-04-11 | Wells Fargo Biotech Forum |
| 2022-03-29 04:30 pm | FY 2021 Earnings Call |
| 2022-03-29 04:05 pm | FY 2021 Earnings Release |
| 2022-03-16 02:40 pm | Oppenheimer Healthcare Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,1 22,0 0.61% | 3,05 3,01 1.36% | 1,72 1,66 3.47% | 1,86 1,70 9.56% | 2,59 13,9 -81.35% |
|
EBITDA Million USD | Released Forecast Spread | -11,7 0,00 - | -45,4 -45,0 -0.99% | -38,0 -38,2 0.49% | -44,6 -45,0 0.88% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -11,9 -13,1 8.99% | -45,7 -45,1 -1.14% | -38,5 -37,6 -2.34% | -45,1 -45,6 1.09% | -44,8 -35,1 -27.66% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,3 -12,5 9.76% | -47,1 -47,4 0.51% | -40,5 -39,7 -2.07% | -45,3 -45,6 0.67% | -44,4 -35,0 -26.79% |
|
Net income Million USD | Released Forecast Spread | -11,3 -12,5 10.08% | -47,1 -47,4 0.66% | -40,5 -39,7 -1.92% | -45,3 -45,4 0.27% | -44,4 -35,0 -26.79% |
|
EPS USD | Released Forecast Spread | -0,20 -0,23 14.31% | -0,83 -0,83 -0.09% | -0,68 -0,67 -1.33% | -0,53 -0,53 0.13% | -0,50 -0,39 -28.21% |
| Announcement Date | 14/03/19 | 03/03/20 | 16/03/21 | 29/03/22 | 28/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,51 0,24 117.69% | 0,43 0,54 -20.79% | 0,45 0,29 56.91% | 0,65 0,26 149.02% | 0,69 0,51 34.05% | 0,71 0,68 5.17% | 0,54 11,9 -95.43% | 0,73 0,30 143.67% |
|
EBITDA Million USD | Released Forecast Spread | -11,1 -11,0 -1.19% | -10,6 -12,0 11.43% | -11,4 -11,0 -3.45% | |||||
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,4 0.99% | -10,8 -12,0 10.33% | -11,5 -12,0 3.82% | -12,4 -11,7 -5.99% | -12,0 -12,8 5.82% | -10,9 -12,5 12.83% | -9,54 -0,48 -1903.78% | -11,5 -9,38 -22.66% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,3 -11,6 3.07% | -10,7 -12,2 11.93% | -11,7 -11,8 1.4% | -12,4 -11,4 -8.72% | -12,0 -13,0 8.06% | -10,7 -12,5 14.04% | -9,23 -10,8 14.91% | -11,0 -9,28 -19.04% |
|
Net income Million USD | Released Forecast Spread | -11,3 -11,6 3.22% | -10,7 -12,0 10.7% | -11,7 -11,7 0.39% | -12,4 -11,9 -4.83% | -12,0 -12,9 6.85% | -10,7 -11,9 10.06% | -9,23 -10,8 14.91% | -11,0 -9,28 -19.04% |
|
EPS USD | Released Forecast Spread | -0,13 -0,14 3.97% | -0,12 -0,13 10.81% | -0,13 -0,13 2.01% | -0,14 -0,14 -2.87% | -0,13 -0,14 8.77% | -0,12 -0,14 11.11% | -0,11 0,00 - | -0,12 -0,11 -14.29% |
| Announcement Date | 27/07/21 | 02/11/21 | 29/03/22 | 03/05/22 | 09/08/22 | 14/11/22 | 28/03/23 | 09/05/23 |
More events
Past sector events for Infinity Pharmaceuticals, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INFI.Q Stock
- Calendar Infinity Pharmaceuticals, Inc.
